Other OTC Pharmaceuticals (Pharmacies) - Cyprus

  • Cyprus
  • Revenue in the Other OTC Pharmaceuticals market is projected to reach US$16.86m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.20%, resulting in a market volume of US$17.90m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$4,981.00m in 2024).
  • In relation to total population figures, per person revenues of US$13.29 are generated in 2024.

Key regions: France, Australia, India, South Korea, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals (Pharmacies) market in Cyprus is experiencing significant growth and development. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors all contribute to this positive trajectory. Customer preferences in Cyprus are shifting towards self-medication and over-the-counter (OTC) pharmaceuticals. This can be attributed to several factors, including the convenience and accessibility of OTC products, the increasing awareness and knowledge of consumers regarding self-care, and the rising healthcare costs. Consumers are becoming more proactive in managing their health and are seeking affordable and easily accessible solutions for common ailments. As a result, there is a growing demand for OTC pharmaceuticals in Cyprus. Trends in the market further support the growth of the Other OTC Pharmaceuticals (Pharmacies) market in Cyprus. The increasing number of pharmacies and the expansion of their product offerings contribute to the availability and accessibility of OTC pharmaceuticals. Pharmacies are also investing in marketing and promotional activities to raise awareness about their products and services, further driving consumer demand. Additionally, advancements in technology and e-commerce have made it easier for consumers to purchase OTC pharmaceuticals online, expanding the reach of the market. Local special circumstances in Cyprus also play a role in the development of the Other OTC Pharmaceuticals (Pharmacies) market. The country has a high prevalence of chronic diseases, such as diabetes and cardiovascular diseases, which require long-term management and medication. This creates a steady demand for OTC pharmaceuticals that cater to the needs of patients with chronic conditions. Furthermore, Cyprus has a large elderly population, who often require OTC medications for common age-related ailments. The aging population contributes to the sustained growth of the market. Underlying macroeconomic factors contribute to the growth of the Other OTC Pharmaceuticals (Pharmacies) market in Cyprus. The country has a stable economy and a relatively high per capita income, which allows consumers to afford OTC pharmaceuticals. Additionally, Cyprus has a well-developed healthcare system, with a strong emphasis on primary care. This supports the demand for OTC pharmaceuticals, as patients are encouraged to manage their health through self-care and preventive measures. In conclusion, the Other OTC Pharmaceuticals (Pharmacies) market in Cyprus is developing due to customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. The shift towards self-medication, the increasing number of pharmacies, the prevalence of chronic diseases, and the stable economy all contribute to the growth and expansion of the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)